AVIA REAVES: Open Payments
NPI 1164076733 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,724 in 68 payments from 21 companies in 2025. Trend: 2023 $1,270 · 2024 $1,469 · 2025 $1,724
Food & beverage: $1,724
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $273 |
| AstraZeneca Pharmaceuticals LP | 7 | $178 |
| PFIZER INC. | 8 | $150 |
| SANOFI-AVENTIS U.S. LLC | 2 | $150 |
| Lilly USA, LLC | 9 | $137 |
| Dexcom, Inc. | 3 | $118 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $104 |
| Otsuka America Pharmaceutical, Inc. | 3 | $90 |
| Amgen Inc. | 5 | $80 |
| Exact Sciences Corporation | 4 | $71 |
Products named: Ozempic, TZIELD, Dexcom G6 Transmitter, MOUNJARO, NURTEC ODT, Kerendia, REXULTI, BREZTRI.
Industry payments across SC — which companies pay providers there.
